Picture not described

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Medtronic (MDT) shares

Learn how to easily invest in Medtronic shares.

Medtronic plc is a medical devices business based in the US. Medtronic shares (MDT) are listed on the NYSE and all prices are listed in US Dollars. Medtronic employs 90,000 staff and has a trailing 12-month revenue of around USD$31.6 billion.

How to buy shares in Medtronic

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MDT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Compare online brokers

warning iconWarning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89 % of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Name Product Standard Brokerage Fee Markets Products
eToro
US stocks: $0
Global
Stocks, ETFs, Currencies
Saxo Markets
Saxo Markets
IE stocks: €12

US stocks: US$7
Global
Stocks, ETFs, Options, Futures, Bonds, Currencies
DEGIRO
IE stocks: €2 + 0.05%

US stocks: €0.5 + US$0.004 per share
Global
Stocks, ETFs, Funds, Options, Futures, Bonds
Zacks Trade
Zacks Trade
IE stocks: No

US stocks: US$1
Global
Stocks, ETFs, Funds, Options, Bonds
loading

Compare up to 4 providers

How has Coronavirus impacted Medtronic's stock price?

Since the stock market crash in March caused by coronavirus, Medtronic's stock price has had significant positive movement.

Its last market close was $121.79, which is 6.99% up on its pre-crash value of $113.28 and 68.85% up on the lowest point reached during the March crash when the stocks fell as low as $72.13.

If you had bought $1,000 worth of Medtronic stocks at the start of February 2020, those stocks would have been worth $618.36 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,032.78.

Is it a good time to buy Medtronic stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Medtronic shares at a glance

Information last updated 2021-10-16.
Latest market close$121.79
52-week range$96.99 - $135.23
50-day moving average $129.22
200-day moving average $127.20
Wall St. target price$145.56
PE ratio 44.6835
Dividend yield $2.37 (1.9%)
Earnings per share (TTM) $2.86

Medtronic stock price (NYSE: MDT)

Use our graph to track the performance of MDT stocks over time.

Medtronic price performance over time

Historical closes compared with the close of $121.79 from 2021-10-20

1 week (2021-10-13) -0.64%
1 month (2021-09-22) -5.52%
3 months (2021-07-22) -4.19%
6 months (2021-04-22) -6.21%
1 year (2020-10-22) 8.90%
2 years (2019-10-22) 16.56%
3 years (2018-10-22) 30.09%
5 years (2016-10-21) 45.14%

Is Medtronic under- or over-valued?

Valuing Medtronic stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medtronic's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Medtronic's P/E ratio

Medtronic's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 45x. In other words, Medtronic shares trade at around 45x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Medtronic's PEG ratio

Medtronic's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.2871. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Medtronic's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Medtronic's EBITDA

Medtronic's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $9.2 billion.

The EBITDA is a measure of a Medtronic's overall financial performance and is widely used to measure a its profitability.

Medtronic financials

Revenue TTM $31.6 billion
Operating margin TTM 20.42%
Gross profit TTM $19.8 billion
Return on assets TTM 4.34%
Return on equity TTM 7.66%
Profit margin 12.29%
Book value $38.29
Market capitalisation $171.9 billion

TTM: trailing 12 months

Shorting Medtronic shares

There are currently 8.5 million Medtronic shares held short by investors – that's known as Medtronic's "short interest". This figure is 20.2% down from 10.6 million last month.

There are a few different ways that this level of interest in shorting Medtronic shares can be evaluated.

Medtronic's "short interest ratio" (SIR)

Medtronic's "short interest ratio" (SIR) is the quantity of Medtronic shares currently shorted divided by the average quantity of Medtronic shares traded daily (recently around 3.8 million). Medtronic's SIR currently stands at 2.26. In other words for every 100,000 Medtronic shares traded daily on the market, roughly 2260 shares are currently held short.

However Medtronic's short interest can also be evaluated against the total number of Medtronic shares, or, against the total number of tradable Medtronic shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Medtronic's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Medtronic shares in existence, roughly 10 shares are currently held short) or 0.0063% of the tradable shares (for every 100,000 tradable Medtronic shares, roughly 6 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Medtronic.

Medtronic's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Medtronic.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Medtronic's total ESG risk score

Total ESG risk: 26.86

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Medtronic's overall score of 26.86 (as at 12/31/2018) is nothing to write home about – landing it in it in the 41st percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Medtronic is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Medtronic's environmental score

Environmental score: 4.07/100

Medtronic's environmental score of 4.07 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Medtronic is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Medtronic's social score

Social score: 15.28/100

Medtronic's social score of 15.28 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Medtronic is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Medtronic's governance score

Governance score: 9/100

Medtronic's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that Medtronic is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Medtronic's controversy score

Controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Medtronic scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Medtronic hasn't always managed to keep its nose clean.

Medtronic share dividends

46%

Dividend payout ratio: 46.36% of net profits

Recently Medtronic has paid out, on average, around 46.36% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.97% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Medtronic shareholders could enjoy a 1.97% return on their shares, in the form of dividend payments. In Medtronic's case, that would currently equate to about $2.37 per share.

While Medtronic's payout ratio might seem fairly standard, it's worth remembering that Medtronic may be investing much of the rest of its net profits in future growth.

Medtronic's most recent dividend payout was on 14 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 22 September 2021 (the "ex-dividend date").

Have Medtronic's shares ever split?

Medtronic's shares were split on a 2:1 basis on 26 September 1999. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Medtronic shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Medtronic shares which in turn could have impacted Medtronic's share price.

Medtronic share price volatility

Over the last 12 months, Medtronic's shares have ranged in value from as little as $96.9878 up to $135.2259. A popular way to gauge a stock's volatility is its "beta".

MDT.US volatility(beta: 0.82)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Medtronic's is 0.8238. This would suggest that Medtronic's shares are less volatile than average (for this exchange).

Medtronic overview

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Medical Surgical Portfolio segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases. The Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked
Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy Policy and Terms.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site